This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Xperi (XPER) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xperi (XPER) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of 29.79% and 3.59%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Xperi (XPER) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Xperi (XPER) closed at $20.77 in the latest trading session, marking a -0.72% move from the prior day.
Xperi Holding (XPER) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Xperi Holding's (XPER) second-quarter 2021 revenues are likely to have increased year over year.
Analysts Estimate Xperi (XPER) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xperi (XPER) Q1 Earnings Top Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of 31.11% and -0.53%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Xperi (XPER) Q1 Earnings Expected to Decline
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xperi (XPER) Earnings Expected to Grow: What to Know Ahead of Q4 Release
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Find Strong Stocks with this New Analyst Coverage Screener
by Benjamin Rains
Investors might want to start to determine how they can improve their 2021 portfolios. One way to find stocks that could be winners is to search for companies that have landed new analyst coverage recently...
Xperi (XPER) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of 58.33% and 9.03%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Xperi (XPER) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xperi (XPER) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Xperi (XPER) delivered earnings and revenue surprises of 1.79% and -21.64%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Xperi (XPER) Q2 Earnings Expected to Decline
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Xperi (XPER) Q1 Earnings Expected to Decline
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GreenSky (GSKY) Looks Good: Stock Adds 7.8% in Session
by Zacks Equity Research
GreenSky (GSKY) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
DocuSign (DOCU) Catches Eye: Stock Jumps 8%
by Zacks Equity Research
DocuSign (DOCU) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Earnings Estimates Moving Higher for Xperi (XPER): Time to Buy?
by Zacks Equity Research
Xperi (XPER) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Top Ranked Momentum Stocks to Buy for February 26th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 26th
Can Xperi (XPER) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Xperi (XPER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Will Xperi Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Xperi.
New Strong Buy Stocks for February 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Can Value Investors Consider Xperi Corporation (XPER) Stock?
by Zacks Equity Research
Xperi Corporation (XPER) stock may be a good choice for value-oriented investors right now from multiple angles.
Will Xperi (XPER) Witness Billings Decline in Q3 Earnings?
by Zacks Equity Research
Xperi Corporation's (XPER) third-quarter 2019 billings are expected to have declined year over year.
Xperi (XPER) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Xperi (XPER) closed at $20.31 in the latest trading session, marking a -1.48% move from the prior day.
Analysts Estimate Xperi (XPER) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Xperi (XPER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.